Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
1.540
-0.025 (-1.60%)
At close: Aug 28, 2026, 4:00 PM EDT
1.550
+0.010 (0.65%)
After-hours: Aug 28, 2026, 7:30 PM EDT

Cadrenal Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-11.54-13.24-10.65-8.36-7.32
Depreciation & Amortization
00.01000
Other Amortization
---0.010.07
Stock-Based Compensation
1.721.941.420.711.01
Other Operating Activities
---03.964.26
Change in Accounts Payable
-0.02-0.851.34-0.240.44
Change in Other Net Operating Assets
-0.32-0.460.540.380.22
Operating Cash Flow
-10.16-12.6-7.36-3.53-1.31
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-0-0.01-0.01-0-0
Investing Cash Flow
-0-0.01-0.01-0-0

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Total Debt Issued
----1.34
Short-Term Debt Repaid
----0.25-
Total Debt Repaid
----0.25-
Net Debt Issued (Repaid)
----0.251.34
Issuance of Common Stock
5.247.165.1412.150.01
Other Financing Activities
1.74-0.563.84--
Financing Cash Flow
6.986.68.9811.91.35

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash Flow
-3.18-6.011.628.370.04

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-10.16-12.61-7.36-3.53-1.32
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-4.28-6.32-6.04-3.93-2.50
Levered Free Cash Flow
-8.54-7.78-3.56-3.92-
Unlevered Free Cash Flow
-8.54-7.78-3.56-3.92-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Change in Working Capital
-0.34-1.311.870.140.66
SEC Filings: 10-K · 10-Q